A Pivotal Study to Evaluate the Efficacy of Lorundrostat in Subjects With Uncontrolled Hypertension on a Standardized Antihypertensive Medication Regimen

NCT05769608 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

285

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: Placebo
DRUG: lorundrostat Dose 1
DRUG: lorundrostat Dose 2

Sponsor

Mineralys Therapeutics Inc.